Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cells

Area of Science:

• Cellular biology
• Biochemistry
• Oncology

Background:

• Oxidative protein folding in the endoplasmic reticulum (ER) is crucial for cellular function.
• Disruptions in ER redox homeostasis trigger an integrated ER stress response, leading to cell death.
• Imexon is a chemotherapeutic agent known to induce oxidative stress, but its precise mechanism remains unclear.

Purpose of the Study:

• To investigate the effects of imexon on the integrated ER stress response in pancreatic carcinoma cells.
• To elucidate the mechanism of imexon-induced cytotoxicity.
• To identify potential therapeutic targets within the ER stress pathway.

Main Methods:

• Acute exposure of pancreatic carcinoma cells to imexon.
• Analysis of ER stress markers including Ero1α oxidation and eIF2α phosphorylation.
• RNA interference screen to identify chemosensitization targets.
• Assessment of intracellular thiol levels and oxidative stress markers.

Main Results:

• Imexon induced an ER stress response, characterized by Ero1α oxidation, eIF2α phosphorylation, and protein synthesis inhibition.
• The eukaryotic translation initiation factor eIF2B5 was identified as a target enhancing imexon-induced growth inhibition.
• Imexon's activity was reversed by reducing intracellular thiols, suggesting thiol binding as a key mechanism.
• Superoxide scavengers did not affect imexon's activity.

Conclusions:

• Imexon disrupts ER redox balance, contributing to its cytotoxic effects in pancreatic cancer cells.
• Targeting ER redox homeostasis presents a potential therapeutic strategy for pancreatic cancer.
• Thiol binding is implicated as a primary mechanism for imexon's oxidative effects.